Apr 29, 2016

Oncolytics Biotech® Inc. to Participate in the Bloom Burton & Co. Healthcare Investor Conference

Apr 29, 2016

Oncolytics Biotech® Inc. Announces Formation of Science and Technology Committee

Apr 18, 2016

Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Research at the 2016 AACR Annual Meeting

Apr 14, 2016

Oncolytics Biotech® Inc. Reports Updated Data from Randomized Phase 2 Study of REOLYSIN® in Pancreatic Cancer

Mar 24, 2016

Oncolytics Biotech® Inc. Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting

Mar 21, 2016

Oncolytics Biotech® Inc. Reports Data from Randomized Phase 2 Study of REOLYSIN® in Ovarian Cancer

Mar 11, 2016

Oncolytics Biotech(R) Inc. Announces 2015 Year End Results

Feb 8, 2016

Media Advisory - Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences

Jan 19, 2016

Oncolytics Biotech® Inc. Announces First Patients Treated in Phase 1b Study in Advanced Pancreatic Cancer

Dec 8, 2015

Oncolytics Biotech® Inc. Collaborators Present Multiple Myeloma Data at 57th American Society of Hematology Annual Meeting